142 related articles for article (PubMed ID: 2718198)
1. Hemostatic markers in acute stroke.
Feinberg WM; Bruck DC; Ring ME; Corrigan JJ
Stroke; 1989 May; 20(5):592-7. PubMed ID: 2718198
[TBL] [Abstract][Full Text] [Related]
2. Activation of coagulation and fibrinolytic systems following stroke.
Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
[TBL] [Abstract][Full Text] [Related]
3. [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
Gando S; Tedo I; Tsujinaga H; Kubota M
Masui; 1988 May; 37(5):541-5. PubMed ID: 3411777
[No Abstract] [Full Text] [Related]
4. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
Marongiu F; Mameli G; Acca MR; Mulas G; Medda A; Tronci MB; Mamusa AM; Balestrieri A
Haemostasis; 1988; 18(2):126-8. PubMed ID: 2457543
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of fibrinopeptide A and fibrinopeptide B beta 15-42 in glomerulonephritis and the nephrotic syndrome.
Tomura S; Oono Y; Kuriyama R; Takeuchi J
Arch Intern Med; 1985 Jun; 145(6):1033-5. PubMed ID: 4004427
[TBL] [Abstract][Full Text] [Related]
6. [Blood coagulation and fibrinolysis in anesthesia and operations, with special reference to FPA, FPB beta 15-42].
Gando S; Tedo I; Hanaoka Y; Makise N; Tsujinaga H; Kubota M
Masui; 1988 Apr; 37(4):451-6. PubMed ID: 3398226
[No Abstract] [Full Text] [Related]
7. In vivo measurements of fibrin formation and fibrinolysis in operable breast cancer.
McCulloch P; Douglas J; Lowe GD; Murray G; George WD
Thromb Haemost; 1989 Apr; 61(2):318-21. PubMed ID: 2749603
[TBL] [Abstract][Full Text] [Related]
8. [Coagulation-fibrinolysis abnormalities in acute stage hypertensive intra-cerebral hemorrhage and head injury (preliminary report). With special reference to fibrinopeptides A and B beta 15-42].
Touho H; Hino A; Suzuki K; Kubo S; Hirakawa K
Neurol Med Chir (Tokyo); 1985 Mar; 25(3):203-8. PubMed ID: 2409465
[No Abstract] [Full Text] [Related]
9. Levels of fibrinopeptide A (FPA) and fibrinopeptide B beta 15-42 (FPB beta) in urine and plasma after urokinase administration in patients with chronic glomerulonephritis.
Miura M; Tomino Y; Inoue W; Yagame M; Tamura S; Nomoto Y; Sakai H
Tokai J Exp Clin Med; 1986 Oct; 11(4):273-7. PubMed ID: 3617111
[TBL] [Abstract][Full Text] [Related]
10. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
Uchiba M; Okajima K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
[No Abstract] [Full Text] [Related]
11. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
Sunakawa M; Arai I; Okinami S
Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
[No Abstract] [Full Text] [Related]
12. [Effects of acid-base balance and Apgar score on fibrinopeptide A and fibrinopeptide B beta 15-42 in umbilical cord blood].
Ogura H; Adachi H; Takeda T; Nakagomi H; Kanno S; Yokoyama M; Kinoshita T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):128-34. PubMed ID: 3102647
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic markers in ischemic stroke of undetermined etiology.
Ince B; Bayram C; Harmanci H; Ulutin T
Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
[TBL] [Abstract][Full Text] [Related]
14. [Plasma fibrinopeptide A, fibrinopeptide B beta 15-42 and 4 other coagulation factors levels in patients with diabetic retinopathy].
Yamamoto M; Denno S; Sunakawa M
Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1443-8. PubMed ID: 1476075
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
Koshihara K; Fuzimaki M
Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
[No Abstract] [Full Text] [Related]
16. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
18. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
Lawler CM; Bovill EG; Stump DC; Collen DJ; Mann KG; Tracy RP
Blood; 1990 Oct; 76(7):1341-8. PubMed ID: 2119827
[TBL] [Abstract][Full Text] [Related]
19. The action of Russell's viper venom on fibrin formation and fibrinolysis in vivo.
Woodhams BJ; Than T; Than T; Hutton RA
Br J Haematol; 1989 Jan; 71(1):107-11. PubMed ID: 2492816
[TBL] [Abstract][Full Text] [Related]
20. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
